Month: December 2022

analysis, analytics, Andreas, app, brand, business, Business Analysis, CA, california, cannabis, compliance, consumer, creative, creativity, cultivation, customer, data, develop, development, director, Dispensaries & Retail, dispensary, Dre, experience, extraction, Federal, government, growing, holdings, illinois, industry, Jushi, law, legal, legalization, legalize, license, marijuana, market, marketing, massachusetts, medical, medicine, MSO, Neumann, nevada, Ohio, Operations, Palm Springs, pennsylvania, platform, presence, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, SKU, state, Sustainability, thc, value, Virginia

Catching up with Jushi Creativity: A Q&A with Dre Neumann

Catching up with Jushi Creativity: A Q&A with Dre Neumann

Jushi Holdings is a large multi-state operator with a massive national footprint and a presence in key markets, including Pennsylvania, Illinois, Virginia, […]

Affinity, analysis, analytics, bio, business, Business Analysis, cannabinoid, cannabis, Christina Diarcangelo, clinical, diabetic, drug, Federal, government, growing, head, industry, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, medical, medicine, nerve, pain, Partners, pharma, pharmaceutical, product, Product Development, Quality, regulation, regulatory, safety, state, studies, Study, test, Testing, therapeutics, to, trial, Zelira

First Pharma vs Cannabis Clinical Trial Moves Forward

First Pharma vs Cannabis Clinical Trial Moves Forward

Affinity Bio Partners on Working with Zelira Therapeutics to Complete Enrolment for Diabetic Nerve Pain Drug Trial It’s an exciting time in […]